Baltimore, MD---Cyril Zaneski provides a detailed look at the reasons behind the
high and unpredictable costs of prescription drugs in America. The article
addresses important issues relative to the often unknown workings of the
pharmacy benefit negotiators to create pharmacy programs for employers and
health plans that increase profits for the pharmacy benefit middlemen. The
$180 billion dollar industry functions in a extremely unpredictable manner
with wide and difficult to explain fluctuations in pricing. For the entire
article, please click here. For a additional information
and background on litigation against the Pharmacy Benefit Managers please visit
the newsroom at www.pbmwatch.org